|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 14, 2018 12:45AM
|
|
Re: Hopefully a late day pop?
|
6
|
Resverlogix Corp.
|
Apr 12, 2018 11:09PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
4
|
Resverlogix Corp.
|
Apr 12, 2018 06:13PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
5
|
Resverlogix Corp.
|
Apr 12, 2018 05:42PM
|
|
Re: Hopefully a late day pop?
|
3
|
Resverlogix Corp.
|
Apr 12, 2018 05:12PM
|
|
Re: Hopefully a late day pop?
|
3
|
Resverlogix Corp.
|
Apr 11, 2018 06:49PM
|
|
Re-jigging the matrix with Third Eye's involvement
|
8
|
Resverlogix Corp.
|
Apr 11, 2018 05:55PM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
5
|
Resverlogix Corp.
|
Apr 11, 2018 07:59AM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
2
|
Zenith Epigenetics
|
Apr 08, 2018 11:23PM
|
|
Re: Wondering?
|
2
|
Resverlogix Corp.
|
Apr 08, 2018 05:35PM
|
|
Re: Wondering?
|
1
|
Resverlogix Corp.
|
Apr 08, 2018 03:37PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 08, 2018 01:16PM
|
|
Re: Que sera sera....
|
3
|
Resverlogix Corp.
|
Apr 03, 2018 06:05AM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Mar 31, 2018 02:46PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 31, 2018 04:11AM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Mar 30, 2018 02:39PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 30, 2018 01:50PM
|
|
Re: Is the message really getting out there
|
9
|
Resverlogix Corp.
|
Mar 28, 2018 02:31PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 23, 2018 11:27PM
|
|
Re: AEGIS-II trial
|
6
|
Resverlogix Corp.
|
Mar 22, 2018 12:35PM
|
